-
Mashup Score: 1
Rohan Garje, MD, discusses considerations when choosing between FDA-approved PARP inhibitor–based combinations for patients with mCRPC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer - 3 day(s) ago
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer - 5 day(s) ago
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer - 12 day(s) ago
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer - 1 month(s) ago
Daniel Spratt, MD, discusses ongoing debate and uncertainties regarding the optimal use of treatment intensification in high-risk prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Innovation Is the Answer to Making Progress Against Cancer - 1 month(s) ago
Shanta Dhar, PhD, FRSC, discusses the significance of being named a fellow of the National Academy of Inventors for her research in prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Taplin Tackles Equitable Treatment in Prostate Cancer - 1 month(s) ago
Mary-Ellen Taplin, MD, discusses ways to mitigate health care disparities in the treatment of patients with prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Enzalutamide Receives Positive EU CHMP Opinion for High-Risk Biochemically Recurrent nmHSPC - 1 month(s) ago
The EMA’s CHMP has recommended the approval of enzalutamide with or without androgen deprivation therapy in biochemically recurrent nmHSPC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Taplin Tackles Equitable Treatment in Prostate Cancer - 1 month(s) ago
Mary-Ellen Taplin, MD, discusses ways to mitigate health care disparities in the treatment of patients with prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Hear from Rohan Garje, MD, @BHCancerCare, as he discusses considerations when choosing between @US_FDA-approved PARP inhibitor–based combinations for patients with mCRPC. #pcsm #oncology https://t.co/zStWH7p0Nn